文献速递流行病学与生物统计真实世界研究与卫生经济

观察性研究可能高估直接口服抗凝药疗效:一项元流行病学分析

Compared to randomized studies, observational studies may overestimate the effectiveness of DOACs: a metaepidemiological approach.
PubMed 文献 · J Clin Epidemiol · 2020-10-17

该元流行病学分析比较了静脉血栓栓塞患者中直接口服抗凝药治疗的随机对照试验与观察性研究。

要点

  • 观察性研究相比RCT可能高估DOACs疗效,但差异未达统计学显著。
  • 前瞻性队列研究疗效估计最有利于治疗,但与RCT差异无统计学意义。
  • 使用活数据库的研究显示疗效高估趋势和安全性效应低估趋势,均不显著。

核心结论

  • 在此临床情境下,观察性研究相比RCT可见治疗疗效估计的夸大。
  • 因不能排除残余混杂,结果应谨慎解读。

研究设计与样本

  • 系统综述鉴定RCT和观察性研究,纳入静脉血栓栓塞接受直接口服抗凝药或常规治疗的患者。
  • 计算观察性研究与RCT比较的风险比比率(RHR)。

主要发现

  • 前瞻性队列研究相比RCT疗效估计增加33%,无统计学意义(RHR 0.67,95%CI 0.39-1.18),安全性估计无影响。
  • 使用活数据库的研究疗效效应更大趋势不显著(RHR 0.82,95%CI 0.66-1.01),安全性效应更小趋势不显著(RHR 1.33,95%CI 0.96-1.84)。
  • 前瞻性队列研究招募的患者选择程度不亚于RCT,其他类型观察性研究可能反映真实治疗人群。

临床怎么用

  • 解读观察性研究显示的DOACs疗效时应考虑可能高估,尤其前瞻性队列研究。
  • 真实世界证据用于疗效评价时需警惕残余混杂,不宜直接替代RCT结论。

局限性

  • 不能排除残余混杂,结果需谨慎解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Randomized controlled trials (RCTs) are criticized for including patients who are overselected. Health authorities consequently encourage "real-world" postmarketing cohort studies. Our objective was to determine the differences between RCTs and observational studies as regards their populations and efficacy/safety results. METHODS: A systematic review was conducted to identify RCTs and observational studies including patients with venous thromboembolism receiving direct oral anticoagulants or conventional treatment. Ratios of hazard ratio (RHR) comparing epidemiological studies (prospective and retrospective cohort studies and studies using living databases) with RCTs were computed. RESULTS: Six RCTs (27,121 patients) and twenty observational studies (248,971 patients) were identified and analyzed. Prospective cohort studies seemed to recruit patients who were no less selected than those of RCTs whereas other types of observational studies may reflect the population treated in real life. Among observational studies, prospective cohort studies yielded the most favorable estimates of treatment effect compared with RCTs. These studies were associated with a nonsignificant 33% increase in efficacy estimate (RHR 0.67, [95% CI, 0.39-1.18]) but no effect on safety estimate. Studies using living databases were associated with nonsignificant trends toward a greater effect on efficacy (RHR 0.82, [0.66-1.01]) and a smaller effect on safety (RHR 1.33, [0.96-1.84]). DISCUSSION: Overall, in this clinical setting, an exaggeration of the treatment efficacy estimate was seen with observational studies compared with RCTs. CONCLUSIONS: As the presence of residual confounding cannot be excluded, these results should be interpreted cautiously.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Safieddine M, Chapelle C, Ollier E, et al. Compared to randomized studies, observational studies may overestimate the effectiveness of DOACs: a metaepidemiological approach. J Clin Epidemiol. 2020. PMID: 33080342. doi:10.1016/j.jclinepi.2020.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。